Business Context and Reporting Period
Company: Compugen Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Second Quarter ended June 30, 2020 (Six months ended June 30, 2020)
Filing Date: July 30, 2020
This filing serves as a cover document incorporating by reference the Company's press release, unaudited interim consolidated financial statements, and Management's Discussion and Analysis (MD&A) for the period.
Key Financial Metrics
The specific numerical values for revenue, profit, cash flow, margins, debt, and liquidity are not contained within the text of this Form 6-K cover document. These figures are located in the incorporated exhibits:
- Exhibit 99.2: Unaudited interim consolidated financial statements (Balance sheets, statements of comprehensive loss, changes in equity, and cash flows).
- Exhibit 99.3: Management's Discussion and Analysis of Results of Operations and Financial Condition.
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. Comparative analysis for the six months ended June 30, 2020 versus June 30, 2019 is contained within the MD&A (Exhibit 99.3) and financial statements (Exhibit 99.2) referenced in this report.
Guidance, Outlook, and Risks
Management commentary, outlook, guidance, risks, contingencies, and unusual items are not detailed in the cover text of this Form 6-K. Investors must refer to:
- Exhibit 99.1: Press Release dated July 30, 2020.
- Exhibit 99.3: Management's Discussion and Analysis.
Investor Verification Checklist
- Review Exhibit 99.2 for specific cash burn rates, total cash and cash equivalents, and debt obligations as of June 30, 2020.
- Examine Exhibit 99.3 for the MD&A to understand the drivers of the net loss and operating expenses for the six-month period.
- Read Exhibit 99.1 (Press Release) for any updates on clinical trial progress, partnership developments, or capital raise activities.
- Verify the incorporation of this Form 6-K into the Company's Registration Statement on Form F-3 (File No. 333-233001).